137 related articles for article (PubMed ID: 20518195)
1. The relationship between sex hormones and the metabolic syndrome.
Lunenfeld B
Acta Biomed; 2010; 81 Suppl 1():79-84. PubMed ID: 20518195
[TBL] [Abstract][Full Text] [Related]
2. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
Traish AM; Guay A; Feeley R; Saad F
J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
[TBL] [Abstract][Full Text] [Related]
3. Hypogonadism and metabolic syndrome: implications for testosterone therapy.
Makhsida N; Shah J; Yan G; Fisch H; Shabsigh R
J Urol; 2005 Sep; 174(3):827-34. PubMed ID: 16093964
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.
Braga-Basaria M; Dobs AS; Muller DC; Carducci MA; John M; Egan J; Basaria S
J Clin Oncol; 2006 Aug; 24(24):3979-83. PubMed ID: 16921050
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer.
Kintzel PE; Chase SL; Schultz LM; O'Rourke TJ
Pharmacotherapy; 2008 Dec; 28(12):1511-22. PubMed ID: 19025432
[TBL] [Abstract][Full Text] [Related]
6. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.
Kalinchenko SY; Tishova YA; Mskhalaya GJ; Gooren LJ; Giltay EJ; Saad F
Clin Endocrinol (Oxf); 2010 Nov; 73(5):602-12. PubMed ID: 20718771
[TBL] [Abstract][Full Text] [Related]
7. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and cardiovascular effects of androgen deprivation therapy.
Hakimian P; Blute M; Kashanian J; Chan S; Silver D; Shabsigh R
BJU Int; 2008 Dec; 102(11):1509-14. PubMed ID: 18727614
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism.
Bojesen A; Kristensen K; Birkebaek NH; Fedder J; Mosekilde L; Bennett P; Laurberg P; Frystyk J; Flyvbjerg A; Christiansen JS; Gravholt CH
Diabetes Care; 2006 Jul; 29(7):1591-8. PubMed ID: 16801584
[TBL] [Abstract][Full Text] [Related]
10. Obesity and androgens: facts and perspectives.
Pasquali R
Fertil Steril; 2006 May; 85(5):1319-40. PubMed ID: 16647374
[TBL] [Abstract][Full Text] [Related]
11. The emerging link between hypogonadism and metabolic syndrome.
Guay AT
J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
[TBL] [Abstract][Full Text] [Related]
12. Androgen deficiency, diabetes, and the metabolic syndrome in men.
Kalyani RR; Dobs AS
Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):226-34. PubMed ID: 17940444
[TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement in men.
Beg S; Al-Khoury L; Cunningham GR
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
[TBL] [Abstract][Full Text] [Related]
14. Relative androgen deficiency in relation to obesity and metabolic status in older men.
Chen RY; Wittert GA; Andrews GR
Diabetes Obes Metab; 2006 Jul; 8(4):429-35. PubMed ID: 16776750
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction.
Traish AM; Feeley RJ; Guay A
FEBS J; 2009 Oct; 276(20):5755-67. PubMed ID: 19754871
[TBL] [Abstract][Full Text] [Related]
16. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
17. Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate.
Haider A; Gooren LJ; Padungtod P; Saad F
Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):167-71. PubMed ID: 19472103
[TBL] [Abstract][Full Text] [Related]
18. [Impact of androgen therapy on metabolic and inflammatory profiles in male hypogonadism].
Chaabouni K; Naifar M; Mejdoub N; Lahyani A; Messedi M; Elleuch A; Turki M; Jamoussi K; Abid M; Ayedi F
Ann Biol Clin (Paris); 2014; 72(6):731-4. PubMed ID: 25486669
[TBL] [Abstract][Full Text] [Related]
19. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
Behre HM; Heinemann L; Morales A; Pexman-Fieth C
Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
[TBL] [Abstract][Full Text] [Related]
20. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome.
Niskanen L; Laaksonen DE; Punnonen K; Mustajoki P; Kaukua J; Rissanen A
Diabetes Obes Metab; 2004 May; 6(3):208-15. PubMed ID: 15056129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
